D-1016-2019 Class II Terminated

Recalled by Advanced Pharma Inc. — Houston, TX

FDA drug recall D-1016-2019 was initiated by Advanced Pharma Inc. on Mar 13, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jan 14, 2020). Affected quantity: 2400 syringes.

Recall details

Product Type
Drugs
Report Date
Mar 27, 2019
Initiation Date
Mar 13, 2019
Termination Date
Jan 14, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2400 syringes

Product description

HYDROmorphone HCl 1 mg in 0.9% Sodium Chloride, QS 5 mL Injectable Solution 1 mg/5 mL (0.2 mg per mL), Sterile single use syringe, NDC: 42852-289-67 Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide

Code information

Lots: 12/03/18 4090 28967S Exp. 4/2/2019; 12/03/18 6221 28967S Exp. 4/2/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1016-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1016-2019. Report a data issue: hello@regdatalab.com.